Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Natural Bioactive Compounds As Protectors Of Mitochondrial Dysfunction In Cardiovascular Diseases And Aging.

Arauna D, Furrianca M, Espinosa-Parrilla Y, Fuentes E, Alarcón M, Palomo I.

Molecules. 2019 Nov 22;24(23). pii: E4259. doi: 10.3390/molecules24234259. Review.

2.

Antiplatelet Activity of Natural Bioactive Extracts from Mango (Mangifera Indica L.) and its By-Products.

Alañón ME, Palomo I, Rodríguez L, Fuentes E, Arráez-Román D, Segura-Carretero A.

Antioxidants (Basel). 2019 Oct 29;8(11). pii: E517. doi: 10.3390/antiox8110517.

3.

Antiplatelet protocol: Effects of ingesting a tomato pomace extract on human platelet aggregation.

Concha-Meyer A, Fuentes E, Palomo I.

MethodsX. 2019 Aug 24;6:1847-1853. doi: 10.1016/j.mex.2019.08.012. eCollection 2019.

4.

Increased platelet function during frailty.

Hernández B, Fuentes E, Palomo I, Alarcón M.

Exp Hematol. 2019 Sep;77:12-25.e2. doi: 10.1016/j.exphem.2019.08.006. Epub 2019 Aug 30.

PMID:
31476327
5.

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders.

Espinosa-Parrilla Y, Gonzalez-Billault C, Fuentes E, Palomo I, Alarcón M.

Front Aging Neurosci. 2019 Jul 2;11:151. doi: 10.3389/fnagi.2019.00151. eCollection 2019. Review.

6.

Lipid Metabolism and Signaling in Platelet Function.

Paes AMA, Gaspar RS, Fuentes E, Wehinger S, Palomo I, Trostchansky A.

Adv Exp Med Biol. 2019;1127:97-115. doi: 10.1007/978-3-030-11488-6_7. Review.

PMID:
31140174
7.

Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies.

Alarcon M, Fuentes E, Maldonado X, Mardones C, Palomo I.

MethodsX. 2019 Apr 29;6:986-992. doi: 10.1016/j.mex.2019.04.023. eCollection 2019.

8.

Chemical Characterization and Antiplatelet Potential of Bioactive Extract from Tomato Pomace (Byproduct of Tomato Paste).

Palomo I, Concha-Meyer A, Lutz M, Said M, Sáez B, Vásquez A, Fuentes E.

Nutrients. 2019 Feb 22;11(2). pii: E456. doi: 10.3390/nu11020456.

9.

Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases.

Lutz M, Fuentes E, Ávila F, Alarcón M, Palomo I.

Molecules. 2019 Jan 21;24(2). pii: E366. doi: 10.3390/molecules24020366. Review.

10.

Analysis of the characteristics and components for the frailty syndrome in older adults from central Chile. The PIEI-ES study.

Palomo I, Giacaman RA, León S, Lobos G, Bustamante M, Wehinger S, Tapia JC, Fuentes M, Alarcón M, García F, Albala C, Fuentes E.

Arch Gerontol Geriatr. 2019 Jan - Feb;80:70-75. doi: 10.1016/j.archger.2018.10.004. Epub 2018 Oct 18.

PMID:
30390427
11.

Platelet mitochondrial dysfunction and mitochondria-targeted quinone-and hydroquinone-derivatives: Review on new strategy of antiplatelet activity.

Fuentes M, Araya-Maturana R, Palomo I, Fuentes E.

Biochem Pharmacol. 2018 Oct;156:215-222. doi: 10.1016/j.bcp.2018.08.035. Epub 2018 Aug 25. Review.

PMID:
30149016
12.

Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules.

Matus MF, Ludueña M, Vilos C, Palomo I, Mariscal MM.

Beilstein J Nanotechnol. 2018 May 2;9:1328-1338. doi: 10.3762/bjnano.9.126. eCollection 2018.

13.

Spatial analysis for the epidemiological study of cardiovascular diseases: A systematic literature search.

Mena C, Sepúlveda C, Fuentes E, Ormazábal Y, Palomo I.

Geospat Health. 2018 May 7;13(1):587. doi: 10.4081/gh.2018.587. Review.

14.

NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis.

Fuentes E, Gibbins JM, Holbrook LM, Palomo I.

Trends Cardiovasc Med. 2018 Oct;28(7):429-434. doi: 10.1016/j.tcm.2018.03.001. Epub 2018 Mar 26. Review.

PMID:
29661712
15.

Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling.

Fuentes M, Sepúlveda C, Alarcón M, Palomo I, Fuentes E.

J Tradit Complement Med. 2017 Mar 19;8(1):66-71. doi: 10.1016/j.jtcme.2017.02.005. eCollection 2018 Jan.

16.

Impact of walkability with regard to physical activity in the prevention of diabetes.

Mena C, Sepúlveda C, Ormazábal Y, Fuentes E, Palomo I.

Geospat Health. 2017 Nov 3;12(2):595. doi: 10.4081/gh.2017.595. Review.

PMID:
29239549
17.

Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors.

Muñoz-Gutiérrez C, Cáceres-Rojas D, Adasme-Carreño F, Palomo I, Fuentes E, Caballero J.

PLoS One. 2017 Dec 7;12(12):e0189213. doi: 10.1371/journal.pone.0189213. eCollection 2017.

18.

Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.

Matus MF, Vilos C, Cisterna BA, Fuentes E, Palomo I.

Vascul Pharmacol. 2018 Feb;101:1-8. doi: 10.1016/j.vph.2017.11.004. Epub 2017 Nov 22. Review.

PMID:
29174014
19.

Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling.

Fuentes F, Alarcón M, Badimon L, Fuentes M, Klotz KN, Vilahur G, Kachler S, Padró T, Palomo I, Fuentes E.

Int J Cardiol. 2017 Dec 1;248:294-300. doi: 10.1016/j.ijcard.2017.08.006. Epub 2017 Aug 7.

PMID:
28811090
20.

Study of the interactions between Edaglitazone and Ciglitazone with PPARγ and their antiplatelet profile.

Muñoz-Gutiérrez C, Sepúlveda C, Caballero J, Palomo I, Fuentes E.

Life Sci. 2017 Oct 1;186:59-65. doi: 10.1016/j.lfs.2017.07.031. Epub 2017 Jul 28.

PMID:
28757415

Supplemental Content

Loading ...
Support Center